Preloader

Study shows rapid improvement in children with MIS-C treated with drug first developed for celiac disease — ScienceDaily

Scientists at Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH) have identified a promising drug candidate for the treatment of multi-inflammatory syndrome in children (MIS-C), they report in…

Metabolism of COVID-19 antibodies from convalescent plasma suggests possible safe treatment for high risk children — ScienceDaily

Johns Hopkins Medicine researchers report that a prospective study of 14 infants and children demonstrated that convalescent plasma — a blood product collected from patients recovered from infections with the…